Avantor PE Ratio 2018-2025 | AVTR

Current and historical p/e ratio for Avantor (AVTR) from 2018 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Avantor PE ratio as of June 06, 2025 is 12.94.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Avantor PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-06-06 13.07 12.57
2025-03-31 16.21 $1.04 15.59
2024-12-31 21.07 $1.04 20.26
2024-09-30 25.87 $0.46 56.24
2024-06-30 21.20 $0.54 39.26
2024-03-31 25.57 $0.39 65.56
2023-12-31 22.83 $0.48 47.56
2023-09-30 21.08 $0.54 39.04
2023-06-30 20.54 $0.63 32.60
2023-03-31 21.14 $0.92 22.98
2022-12-31 21.09 $1.02 20.68
2022-09-30 19.60 $0.94 20.85
2022-06-30 31.10 $0.93 33.44
2022-03-31 33.82 $0.89 38.00
2021-12-31 42.14 $0.86 49.00
2021-09-30 40.90 $0.79 51.77
2021-06-30 35.51 $0.45 78.91
2021-03-31 28.93 $0.29 99.76
2020-12-31 28.15 $0.09 312.78
2020-09-30 22.49 $0.12 187.42
2020-06-30 17.00 $0.23 73.91
2020-03-31 12.49 $-0.83 0.00
Sector Industry Market Cap Revenue
Medical Medical Services $8.906B $6.784B
Avantor Inc. is a provider of critical products and services primarily to biopharma, healthcare, education & government, advanced technologies & applied materials industries. Avantor Inc. is based in Radnor, United States.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $140.286B 26.31
Elevance Health (ELV) United States $88.874B 11.47
CVS Health (CVS) United States $80.430B 10.00
Cencora (COR) United States $56.003B 19.48
DiDi Global (DIDIY) China $23.532B 35.71
Natera (NTRA) United States $22.361B 0.00
BioMerieux (BMXMF) France $16.097B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $12.999B 0.00
Solventum (SOLV) United States $12.948B 13.71
CochLear (CHEOY) Australia $11.388B 0.00
ICON (ICLR) Ireland $11.234B 10.44
Doximity (DOCS) United States $11.054B 51.17
Revvity (RVTY) United States $10.840B 18.66
Viatris (VTRS) United States $10.223B 3.51
HealthEquity (HQY) United States $9.646B 42.25
Medpace Holdings (MEDP) United States $8.522B 22.63
Sonic Healthcare (SKHHY) Australia $8.301B 0.00
Charles River Laboratories (CRL) United States $7.107B 13.93
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
BrightSpring Health Services (BTSG) United States $4.201B 38.89
Bausch + Lomb (BLCO) Canada $4.139B 24.38
Sotera Health (SHC) United States $3.491B 19.84
Alignment Healthcare (ALHC) United States $3.011B 0.00
Surgery Partners (SGRY) United States $2.972B 38.65
Concentras Parent (CON) United States $2.824B 16.32
Organon (OGN) United States $2.485B 2.64
Ardent Health Partners (ARDT) United States $2.126B 9.06
GeneDx Holdings (WGS) United States $2.056B 79.20
Premier (PINC) United States $1.889B 14.33
Progyny (PGNY) United States $1.858B 40.91
PACS (PACS) United States $1.591B 0.00
GoodRx Holdings (GDRX) United States $1.457B 29.14
Teladoc Health (TDOC) United States $1.275B 0.00
Pediatrix Medical (MD) United States $1.210B 9.21
Establishment Labs Holdings (ESTA) $1.099B 0.00
CareDx (CDNA) United States $1.087B 16.97
Ryman Healthcare (RYHTY) New Zealand $1.011B 0.00
Agilon Health (AGL) United States $0.894B 0.00
AMN Healthcare Services Inc (AMN) United States $0.808B 7.56
QDM (QDMI) Hong Kong, SAR China $0.755B 0.00
Nutex Health (NUTX) United States $0.678B 10.26
LifeMD (LFMD) United States $0.578B 0.00
Embecta (EMBC) United States $0.572B 3.85
Enhabit (EHAB) United States $0.547B 45.00
InnovAge Holding (INNV) United States $0.543B 0.00
SBC Medicals (SBC) United States $0.489B 0.00
Auna S.A (AUNA) Luxembourg $0.482B 10.85
Sonida Senior Living (SNDA) United States $0.478B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.449B 0.00
Oncology Institute (TOI) United States $0.248B 0.00
Performant Healthcare (PHLT) United States $0.244B 0.00
Beauty Health (SKIN) United States $0.202B 0.00
DocGo (DCGO) United States $0.156B 25.50
KindlyMD (KDLY) United States $0.150B 0.00
KindlyMD (NAKA) United States $0.096B 0.00
So-Young (SY) China $0.092B 0.00
Pheton Holdings (PTHL) China $0.089B 0.00
OncoCyte (OCX) United States $0.085B 0.00
Basel Medical Group (BMGL) Singapore $0.073B 0.00
Ascend Wellness Holdings (AAWH) United States $0.065B 0.00
NeueHealth (NEUE) United States $0.060B 0.00
Sera Prognostics (SERA) United States $0.058B 0.00
ModivCare (MODV) United States $0.057B 0.00
IceCure Medical (ICCM) Israel $0.056B 0.00
Biodesix (BDSX) United States $0.044B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.029B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
Intelligent Bio Solutions (INBS) United States $0.011B 0.00
Co-Diagnostics (CODX) United States $0.010B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
INVO Fertility (IVF) United States $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00